Discovery of Benzothiazinone and Quinazolinedione Carboxamides as Low-Nanomolar Soluble Epoxide Hydrolase Inhibitors

Authors: Caliskan, Kubra; Karatas, Mehmet; Caliskan, Burcu; Jordan, Paul M; Werz, Oliver; Banoglu, Erden

Source journal: Archiv der Pharmazie (2026-11-01)

DOI: 10.1002/ardp.70383

Abstract

The metabolism of arachidonic acid via the cytochrome P450 pathway yields anti-inflammatory epoxyeicosatrienoic acids (EETs), which are rapidly hydrolyzed to the less active diols by soluble epoxide hydrolase (sEH). Traditional sEH inhibitors rely on rigid urea-based compounds that are often limited by poor physicochemical properties; therefore, structurally distinct non-urea chemotypes remain desirable. Inspired by crystallographic fragment screening, we designed, synthesized, and evaluated 12 fused heterocyclic carboxamides spanning five core scaffolds as sEH inhibitors. The benzothiazin-3-one and quinazoline-2,4-dione cores proved most favorable, affording FP2 (IC(50) = 4.1 nM) and FP5 (IC(50) = 10.0 nM) in the initial series; variation of the flanking benzylamide of the benzothiazin-3-one core then gave FP9-FP12, among which FP12 was the most potent inhibitor obtained (IC(50) = 1.4 nM). Similarity analysis against 2521 known ChEMBL sEH inhibitors gave maximum ECFP4 Tanimoto coefficients of 0.446-0.623, supporting the structural distinctness of the series. Molecular docking and molecular dynamics simulations indicate recurrent engagement of the catalytic residues Asp335 and Tyr383, albeit with trajectory-dependent conformational variability. Initial profiling of FP2 and FP5 revealed chemotype-dependent liabilities: high aqueous solubility but rapid microsomal clearance for FP2, markedly lower solubility for FP5, identifying these carboxamide scaffolds as structurally novel starting points for further optimization.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.